News

Global Times: 15 years on, China's Nasdaq-style ChiNext board drives innovative economic growth
October 31, 2024 04:50 PM AEDT| By CisionBEIJING, Oct. 31, 2024 /PRNewswire/ -- Wednesday marked the 15th anniversary of the ChiNext board, a Nasdaq-style board for growth enterprises in China, which opened for trading on October 30, 20...

CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK
October 31, 2024 04:00 PM AEDT| By CisionThis approval marks the second international marketing authorization for sugemalimab outside of China, following its recent approval by the European Commission. The approval is based on results...

Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC
October 31, 2024 03:02 PM AEDT| By CisionCHENGDU, China, Oct. 31, 2024 /PRNewswire/ -- The new drug application (NDA) (the "Application") based on the positive results from the pivotal phase III OptiTROP-Lung04 study of sacitu...

Toshiba and Naturenix Launch Demonstration Test of Battery Subscription Service for Electric Motorcycle Taxis in Bangkok
October 31, 2024 03:00 PM AEDT| By Cision- Developing markets in emerging economies by utilizing SCiB™*1 with long life performance in hot environments - TOKYO, Oct. 31, 2024 /PRNewswire/ -- Toshiba Corporation and Natureni...

Breakthrough Australian Cancer trial: retraining immune cells offers new hope for patients
October 31, 2024 03:00 PM AEDT| By CisionADELAIDE, Australia and BOSTON, Oct. 31, 2024 /PRNewswire/ -- In a remarkable development for cancer research, Australian patients with advanced-stage cancer have benefited from SUPLEXA, a pers...

EQT Acquires Leading SaaS Talent Solutions Provider PageUp to Accelerate Global Expansion and Product Innovation
October 31, 2024 02:35 PM AEDT| By CisionPageUp will leverage EQT's expertise to accelerate international expansion and drive product innovation in talent management software. EQT's investment builds on PageUp's strong track record of expan...

Eat Like a Shogun in Saitama-Kawaguchi -November 2024 to January 2025
October 31, 2024 02:03 PM AEDT| By CisionKAWAGUCHI, Japan, Oct. 30, 2024 /PRNewswire/ -- A new tour held at Shakujoji Temple, in the city of Kawaguchi in Saitama Prefecture,allows visitors to experience a day in the life of a shogun, tr...

The 2024 Asia Green and Low-Carbon Development Roundtable was held
October 31, 2024 01:54 PM AEDT| By CisionQINGDAO, China, Oct. 31, 2024 /PRNewswire/ -- On October 24, the Smart Energy Sub-forum of the Third Belt and Road Energy Ministerial Conference and 2024 Asia Green and Low-Carbon Development Roundtab...

MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024
October 31, 2024 01:51 PM AEDT| By CisionSHENZHEN, China, Oct. 31, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, is t...

AIKO Showcases its High-Efficiency N-type ABC Modules at All Energy Australia
October 31, 2024 01:44 PM AEDT| By CisionMELBOURNE, Australia, Oct. 31, 2024 /PRNewswire/ -- AIKO made an impactful debut at Melbourne's premier energy event, All Energy Australia, which kicked off on October 23, 2024, in Melbourne. The comp...

Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration
October 31, 2024 01:26 PM AEDT| By CisionDONGGUAN, China, Oct. 31, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is thrilled to announce its PSP CLIA reagent solution which demonstrates promising outcomes in...

TIER IV's AI Pilot system certified for Level 4 autonomous bus service in Nagano Prefecture
October 31, 2024 01:23 PM AEDT| By CisionTOKYO, Oct. 31, 2024 /PRNewswire/ -- TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, is proud to announce Level 4*1 certification f...

The 35kV power grid project has been put into operation and will provide power transmission to support local economic development
October 31, 2024 12:20 PM AEDT| By CisionKUITUN, China, Oct. 31, 2024 /PRNewswire/ -- The temperature measurement of the 35 kV Yuxing line is normal, and no defects or hidden dangers were found during the inspection. On October 30th, staff f...

Regal Hotels Pioneers Green Meetings Elevating Sustainable Practices for MICE Events in Hong Kong
October 31, 2024 12:20 PM AEDT| By CisionHONG KONG, Oct. 30, 2024 /PRNewswire/ -- Regal Hotels is proud to introduce Green Meetings, a unique, all-in-one business solution designed to empower event organisers to achieve their sustaina...

ANGEL Shines at FHA HoReCa 2024 with Leading Water Purification Solutions
October 31, 2024 12:05 PM AEDT| By CisionSINGAPORE, Oct. 31, 2024 /PRNewswire/ -- FHA HoReCa 2024, Asia's leading foodservice and hospitality tradeshow, took place from October 22-25 at the Singapore EXPO. FHA HoReCa focused on the latest tr...

A bond forged through the fragrance
October 31, 2024 12:00 PM AEDT| By CisionGONGQINGCHENG, China, Oct. 31, 2024 /PRNewswire/ -- A report from Jiangxi International Communication Center(JXICC): In Gongqingcheng, there is an intangible heritage called Tan Hua Fragranc...

Hyundai Motor Reveals Bold and Efficient Hydrogen FCEV Concept Previewing New Design Language
October 31, 2024 12:00 PM AEDT| By CisionHyundai unveils its INITIUM hydrogen fuel cell electric concept vehicle, reinforcing its clear commitment to hydrogen mobility and sustainability The concept showcases the company's new design l...

AXOR Makes a Grand Debut at EICMA 2024, Milan: A Global Stage for Innovation and Rider Safety
October 31, 2024 12:00 PM AEDT| By CisionBELGAUM, India, Oct. 31, 2024 /PRNewswire/ -- AXOR, a leading international helmet brand and a subsidiary of the renowned VEGA Auto, is gearing up for its much-anticipated debut at EICMA 2024,...

Agoda Highlights 7 Ski Destinations for Winter Sport Enthusiasts
October 31, 2024 12:00 PM AEDT| By CisionSINGAPORE, Oct. 31, 2024 /PRNewswire/ -- As the year draws to a close and winter sets in on the Northern hemisphere, many travelers look to the slopes for their seasonal adventures. Digital tra...

Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab
October 31, 2024 11:46 AM AEDT| By CisionHONG KONG, Oct. 31, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized, controlled, multicenter Phase III clinical study (...
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.